Mucolipidosis Type Iv Foundation Inc
Mucolipidosis Type IV Foundation shows strong financial growth and zero executive compensation.
EIN: 133633501 · Atlanta, GA · NTEE: G20 · Updated: 2026-03-28
Is Mucolipidosis Type Iv Foundation Inc Legit?
Some Concerns
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
Mucolipidosis Type Iv Foundation Inc directs 90% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.
About Mucolipidosis Type Iv Foundation Inc
Mucolipidosis Type Iv Foundation Inc (EIN: 133633501) is a nonprofit organization based in Atlanta, GA, classified under NTEE code G20. The organization reported total revenue of $3.8M and total assets of $2.2M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Mucolipidosis Type Iv Foundation Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Mucolipidosis Type Iv Foundation Inc is a mid-size nonprofit that has been operating for 14 years, with 16 years of IRS 990 filings on record (2009–2023). Revenue has grown at a compound annual rate of 26.8%.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
| Total Revenue | $1.1M |
| Total Expenses | $656K |
| Surplus / Deficit | +$425K |
| Total Assets | $1.5M |
| Total Liabilities | $6K |
| Net Assets | $1.5M |
| Operating Margin | 39.3% |
| Debt-to-Asset Ratio | 0.4% |
| Months of Reserves | 27.0 months |
Financial Health Grade: A
In 2023, Mucolipidosis Type Iv Foundation Inc reported a surplus of $425K with revenue exceeding expenses, holds 27.0 months of operating reserves (strong position), has a debt-to-asset ratio of 0.4% (very low leverage).
Financial Trends
Over 16 years of filings (2009–2023), Mucolipidosis Type Iv Foundation Inc's revenue has grown at a compound annual growth rate (CAGR) of 26.8%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2023 | +25.7% | +0.5% | +41.0% |
| 2022 | +27.2% | -8.7% | +24.7% |
| 2021 | +3.7% | +61.8% | -7.3% |
| 2020 | -16.5% | +19.0% | +35.3% |
| 2019 | +58.4% | -51.4% | +145.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2012 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Transparency Report
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Mucolipidosis Type Iv Foundation Inc with a Mission Score of 92 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Spending Breakdown
- admin: 7%
- programs: 90%
- fundraising: 3%
According to IRS 990 filings, Mucolipidosis Type Iv Foundation Inc allocates its expenses as follows: admin: 7%, programs: 90%, fundraising: 3%. With 90% directed toward programs, this reflects a strong commitment to its charitable mission.
Key Financial Metrics (2023)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $425K, with revenue exceeding expenses.
- Debt-to-asset ratio: 0.4%.
Executive Compensation Analysis
Executive compensation is consistently reported as 0% across all available filings, indicating that the organization's leadership is either unpaid or compensated through other means not reported as officer compensation, which is highly unusual for an organization of its size with over $1 million in annual revenue.
Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.
Red Flags
The following concerns were identified during AI analysis of Mucolipidosis Type Iv Foundation Inc's IRS 990 filings:
- Consistent 0% officer compensation for an organization of this size could indicate compensation is reported under other expense categories or that leadership is entirely volunteer, which, while potentially positive, warrants further investigation for full transparency.
Strengths
The following positive indicators were identified for Mucolipidosis Type Iv Foundation Inc:
- Strong and consistent revenue growth over the past decade, from $297,209 in 2014 to $1,080,997 in 2023.
- Healthy asset-to-liability ratio, with assets of $1,477,459 significantly exceeding liabilities of $6,431 in 2023.
- Excellent transparency with 16 publicly available IRS 990 filings.
- Zero reported officer compensation across all filings, suggesting a high dedication of funds to mission-related activities.
- Positive net assets growth, indicating financial health and sustainability.
Frequently Asked Questions about Mucolipidosis Type Iv Foundation Inc
Is Mucolipidosis Type Iv Foundation Inc a legitimate charity?
Based on AI analysis of IRS 990 filings, Mucolipidosis Type Iv Foundation Inc (EIN: 133633501) some concerns. Mission Score: 92/100. 1 red flag identified, 5 strengths noted.
How does Mucolipidosis Type Iv Foundation Inc spend its money?
Mucolipidosis Type Iv Foundation Inc directs 90% of its spending to programs and services. The remaining budget covers administration and fundraising costs.
Are donations to Mucolipidosis Type Iv Foundation Inc tax-deductible?
Mucolipidosis Type Iv Foundation Inc is registered as a tax-exempt nonprofit (EIN: 133633501). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Is Mucolipidosis Type Iv Foundation Inc. financially stable?
Yes, the organization appears financially stable, demonstrating consistent revenue growth from $297,209 in 2014 to $1,080,997 in 2023, and a healthy asset base of $1,477,459 against minimal liabilities of $6,431 in 2023.
How efficiently does the organization spend its money?
The organization appears highly efficient, especially given the consistent reporting of 0% officer compensation across all filings, suggesting a very high proportion of expenses are directed towards programs and operational needs.
What is the trend in the organization's revenue?
The organization has shown a strong upward trend in revenue, growing from $297,209 in 2014 to $1,080,997 in 2023, indicating increasing support and financial capacity.
Does the organization have significant liabilities?
No, the organization has very low liabilities, reported at only $6,431 in 2023, which is negligible compared to its assets of $1,477,459.
Filing History
IRS 990 filing history for Mucolipidosis Type Iv Foundation Inc showing financial trends over 16 years of public records:
Over 16 years of IRS 990 filings (2009–2023), Mucolipidosis Type Iv Foundation Inc's revenue has grown by 2688.2%, moving from $39K to $1.1M. Total assets increased by 830% over the same period, from $159K to $1.5M. Total functional expenses rose by 1053.9%, from $57K to $656K. In its most recent filing year (2023), Mucolipidosis Type Iv Foundation Inc reported a surplus of $425K, with revenue exceeding expenses. The organization holds $6K in liabilities against $1.5M in assets (debt-to-asset ratio: 0.4%), resulting in net assets of $1.5M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2023 | $1.1M | $656K | $1.5M | $6K | — | — |
| 2022 | $860K | $653K | $1.0M | $1K | — | View 990 |
| 2021 | $676K | $716K | $840K | $748 | — | View 990 |
| 2020 | $653K | $442K | $906K | $27K | — | View 990 |
| 2019 | $782K | $372K | $669K | $2K | — | View 990 |
| 2018 | $494K | $765K | $273K | $15K | — | View 990 |
| 2017 | $499K | $527K | $531K | $2K | — | View 990 |
| 2016 | $459K | $464K | $557K | $210 | — | View 990 |
| 2015 | $306K | $339K | $562K | $0 | — | View 990 |
| 2014 | $297K | $225K | $595K | $0 | — | View 990 |
| 2013 | $126K | $62K | $523K | $0 | — | View 990 |
| 2013 | $223K | $210K | $459K | $0 | — | View 990 |
| 2012 | $333K | $84K | $446K | $0 | — | View 990 |
| 2011 | $42K | $29K | $196K | $0 | — | View 990 |
| 2010 | $32K | $8K | $184K | $0 | — | View 990 |
| 2009 | $39K | $57K | $159K | $0 | — | View 990 |
Year-by-Year Financial Summary
- 2023: Revenue of $1.1M, expenses of $656K, and assets of $1.5M (revenue +25.7% year-over-year).
- 2022: Revenue of $860K, expenses of $653K, and assets of $1.0M (revenue +27.2% year-over-year).
- 2021: Revenue of $676K, expenses of $716K, and assets of $840K (revenue +3.7% year-over-year).
- 2020: Revenue of $653K, expenses of $442K, and assets of $906K (revenue -16.5% year-over-year).
- 2019: Revenue of $782K, expenses of $372K, and assets of $669K (revenue +58.4% year-over-year).
- 2018: Revenue of $494K, expenses of $765K, and assets of $273K (revenue -1.1% year-over-year).
- 2017: Revenue of $499K, expenses of $527K, and assets of $531K (revenue +8.7% year-over-year).
- 2016: Revenue of $459K, expenses of $464K, and assets of $557K (revenue +50.1% year-over-year).
- 2015: Revenue of $306K, expenses of $339K, and assets of $562K (revenue +2.9% year-over-year).
- 2014: Revenue of $297K, expenses of $225K, and assets of $595K (revenue +135.3% year-over-year).
- 2013: Revenue of $126K, expenses of $62K, and assets of $523K (revenue -43.4% year-over-year).
- 2013: Revenue of $223K, expenses of $210K, and assets of $459K (revenue -33.0% year-over-year).
- 2012: Revenue of $333K, expenses of $84K, and assets of $446K (revenue +701.1% year-over-year).
- 2011: Revenue of $42K, expenses of $29K, and assets of $196K (revenue +28.0% year-over-year).
- 2010: Revenue of $32K, expenses of $8K, and assets of $184K (revenue -16.3% year-over-year).
- 2009: Revenue of $39K, expenses of $57K, and assets of $159K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Mucolipidosis Type Iv Foundation Inc:
Data Sources and Methodology
This transparency report for Mucolipidosis Type Iv Foundation Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.